प्लान में उपलब्ध है
एक साथ कई कंपनियों का विश्लेषण करना चाहते हैं? सशुल्क प्लान में आप अधिकतम 5 शेयरों की साथ-साथ तुलना कर सकते हैं।
साइन अप करें
LAB
vs
S&P 500
LAB
S&P 500
पिछले 12 महीने में LAB ने S&P 500 से कमजोर प्रदर्शन किया। इसका रिटर्न -48% रहा, जबकि S&P 500 में +14% की वृद्धि हुई।
शेयरों का प्रदर्शन
LAB vs S&P 500
प्रदर्शन में अंतर
LAB vs S&P 500
वर्ष के अनुसार प्रदर्शन
LAB vs S&P 500
शेयर के रिटर्न की तुलना उसके बेंचमार्क सूचकांक और प्रतिस्पर्धियों से करें। समय के साथ उसके सापेक्ष प्रदर्शन को समझें।
Standard BioTools Inc
एक नज़र में
Standard BioTools makes laboratory instruments and consumables used by researchers who study cells, proteins, and genes. Its products help scientists measure many biological targets from very small samples, especially in academic labs, biotech companies, and pharmaceutical research centers. The company sells hardware, test kits, and related reagents that are used together in recurring experiments. The business makes money in two main ways: selling instruments up front and then selling the consumables and assays those instruments require over time. That mix matters because the installed machines create repeat demand for follow-on products. Standard BioTools sits in the life-science research supply chain, where customers buy specialized tools to generate data for discovery, disease research, and drug development. What makes the company different is its focus on high-content measurement platforms for small, precious samples. Instead of general lab equipment, it builds instruments designed to run specific biological tests with a high degree of precision and workflow control. That gives Standard BioTools a niche role as a specialist supplier to scientists who need detailed information from limited material.